Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Argus Health
Federal Trade Commission
Novartis
Fish and Richardson
Chubb
McKesson
UBS
Covington
Fuji

Generated: January 17, 2018

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride; fluocinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ciprofloxacin hydrochloride; fluocinolone acetonide and what is the scope of ciprofloxacin hydrochloride; fluocinolone acetonide freedom to operate?

Ciprofloxacin hydrochloride; fluocinolone acetonide
is the generic ingredient in one branded drug marketed by Laboratorios Salvat and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride; fluocinolone acetonide has sixteen patent family members in thirteen countries.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride; fluocinolone acetonide. One supplier is listed for this compound.
Summary for ciprofloxacin hydrochloride; fluocinolone acetonide
Pharmacology for ciprofloxacin hydrochloride; fluocinolone acetonide

US Patents and Regulatory Information for ciprofloxacin hydrochloride; fluocinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Laboratorios Salvat OTOVEL ciprofloxacin hydrochloride; fluocinolone acetonide SOLUTION/DROPS;OTIC 208251-001 Apr 29, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Laboratorios Salvat OTOVEL ciprofloxacin hydrochloride; fluocinolone acetonide SOLUTION/DROPS;OTIC 208251-001 Apr 29, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ciprofloxacin hydrochloride; fluocinolone acetonide

Supplementary Protection Certificates for ciprofloxacin hydrochloride; fluocinolone acetonide

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012 France ➤ Subscribe PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB12/058 United Kingdom ➤ Subscribe PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Healthtrust
Express Scripts
Moodys
Citi
Julphar
Daiichi Sankyo
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot